Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04400539 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The IMmunotherapy Pleural 5-ALA PDT

Study acronym: IMPALA
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 25, 2025 (before its estimated May 9, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: May 2026 to May 9, 2026v6
  2. Collaborator revisedv5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Primary and study completion dates: Apr 2026 to May 2026
    • Start date changed from estimate of Apr 2022 to May 9, 2022
    v4
  4. Primary and study completion dates: Sep 2025 to Apr 2026
    • Start date: Sep 2021 to Apr 2022
    • Collaborator revised
    v3
  5. Primary and study completion dates: Sep 2024 to Sep 2025
    • Start date: Sep 2020 to Sep 2021
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pilot study of the feasibility of an innovative multimodal treatment combining intrapleural photodynamic therapy with videothoracoscopy followed by adjuvant immunotherapy with anti-PD-1 Nivolumab antibodies in patients with malignant pleural mesothelioma
Trial Details
NCT Number NCT04400539
Lead Sponsor University Hospital, Lille
Collaborators: INSERM U1189 ONCOTHAI
Conditions
(from sponsor)		 Mesotheliomas Pleural, Malignant Pleural Mesothelioma
Related terms Mesothelioma, Malignant
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov